ZNF295 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.769600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.682200E-01
Normal-vs-Stage2
8.482600E-01
Normal-vs-Stage3
4.637600E-01
Normal-vs-Stage4
2.217000E-01
Stage1-vs-Stage2
9.139400E-01
Stage1-vs-Stage3
4.049800E-01
Stage1-vs-Stage4
8.462300E-02
Stage2-vs-Stage3
4.794800E-01
Stage2-vs-Stage4
5.296300E-02
Stage3-vs-Stage4
8.965700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.629000E-01
Normal-vs-AfricanAmerican
5.567800E-01
Normal-vs-Asian
3.827600E-01
Caucasian-vs-AfricanAmerican
2.021200E-01
Caucasian-vs-Asian
2.350400E-01
AfricanAmerican-vs-Asian
7.936300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.216800E-01
Normal-vs-Female
9.595600E-01
Male-vs-Female
4.911000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.920000E-01
Normal-vs-Age(41-60Yrs)
7.394200E-01
Normal-vs-Age(61-80Yrs)
7.579800E-01
Normal-vs-Age(81-100Yrs)
1.434150E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.339800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.622800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.299950E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.449500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.145610E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.706150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.987600E-01
Normal-vs-Daily Drinker
4.661800E-01
Normal-vs-Weekly Drinker
8.572600E-01
Normal-vs-Occasional Drinker
8.079000E-01
Normal-vs-Social Drinker
8.652000E-01
Non Drinker-vs-Daily Drinker
9.323200E-01
Non Drinker-vs-Weekly Drinker
1.450010E-01
Non Drinker-vs-Occasional Drinker
1.563040E-01
Non Drinker-vs-Social Drinker
1.634440E-01
Daily Drinker-vs-Weekly Drinker
1.470600E-01
Daily Drinker-vs-Occasional Drinker
2.946600E-01
Daily Drinker-vs-Social Drinker
1.614810E-01
Weekly Drinker-vs-Occasional Drinker
5.183600E-01
Weekly Drinker-vs-Social Drinker
9.911400E-01
Occasional Drinker-vs-Social Drinker
5.311200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.147980E-01
Normal-vs-Grade 2
3.966000E-02
Normal-vs-Grade 3
5.006000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.442000E-01
Grade 1-vs-Grade 3
7.266800E-01
Grade 1-vs-Grade 4
1.147980E-01
Grade 2-vs-Grade 3
5.555600E-01
Grade 2-vs-Grade 4
3.966000E-02
Grade 3-vs-Grade 4
5.006000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.983400E-01
Normal-vs-NonDiabetic
6.743600E-01
Diabetic-vs-NonDiabetic
7.414600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.283400E-01
Normal-vs-NoPancreatitis
7.643200E-01
Pancreatitis-vs-NoPancreatitis
6.812400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.970400E-01
Normal-vs-N1
9.046600E-01
N0-vs-N1
6.388000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.301000E-01
Normal-vs-TP53-NonMutant
8.030400E-01
TP53-Mutant-vs-TP53-NonMutant
1.124030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
